메뉴 건너뛰기




Volumn 72, Issue 10, 2012, Pages 1299-1312

Corticosteroid resistance and novel anti-inflammatory therapies in chronic obstructive pulmonary disease: Current evidence and future direction

Author keywords

Beclometasone; Bronchodilators; Budesonide; Budesonideformoterol; Chemokine receptor antagonists; Chemokines; Chronic obstructive pulmonary disease; Corticosteroids; Drug resistance; Fluticasone propionate; Histone deacetylase activity; Infliximab; Inhalation; Matrix metalloproteinase 12 inhibitors; Matrix metalloproteinase 9 inhibitors; Roflumilast; Salmeterol; Salmeterolfluticasone propionate; Theophylline; Tiotropium bromide; Tocilizumab; Tumour necrosis factor alpha

Indexed keywords

4 (2 AMINOETHYLAMINO) 1,8 DIMETHYLIMIDAZO[1,2 A]QUINOXALINE; 6 CHLORO 8 NICOTINAMIDO BETA CARBOLINE; ADZ 8309; ANTIINFLAMMATORY AGENT; AZ 11557272; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BIOFUEL; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CIGARETTE SMOKE; CORTICOSTEROID; CYTOKINE; DILAMPIMOD; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; GLUCOCORTICOID RECEPTOR; GSK 256066; HEAT SHOCK PROTEIN 90; HISTONE DEACETYLASE 2; INFLIXIMAB; LONG ACTING BETA 2 ADRENERGIC RECEPTOR AGONIST; PH 797804; PLACEBO; REACTIVE OXYGEN METABOLITE; ROFLUMILAST; RPL 554; SALMETEROL; SD 282; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 84863224541     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11634350-000000000-00000     Document Type: Article
Times cited : (33)

References (105)
  • 1
    • 33646799069 scopus 로고    scopus 로고
    • Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data
    • DOI 10.1016/S0140-6736(06)68770-9, PII S0140673606687709
    • Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006 May 27; 367 (9524): 1747-57 (Pubitemid 43767064)
    • (2006) Lancet , vol.367 , Issue.9524 , pp. 1747-1757
    • Lopez, A.D.1    Mathers, C.D.2    Ezzati, M.3    Jamison, D.T.4    Murray, C.J.5
  • 2
    • 34249742714 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease: A growing but neglected global epidemic
    • May
    • Barnes PJ. Chronic obstructive pulmonary disease: a growing but neglected global epidemic. PLoS Med 2007 May; 4 (5): e112
    • (2007) PLoS Med , vol.4 , Issue.5
    • Barnes, P.J.1
  • 4
    • 34147214922 scopus 로고    scopus 로고
    • Global Initiative for Chronic Obstructive Lung Disease (GOLD) [online] [Accessed 2012 Jun 7]
    • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. 2011 [online]. Available from URL: http://www.goldcopd.org/[Accessed 2012 Jun 7]
    • (2011) Global Strategy for the Diagnosis, Management and Prevention of COPD
  • 5
    • 34548222188 scopus 로고    scopus 로고
    • Global burden of COPD: risk factors, prevalence, and future trends
    • DOI 10.1016/S0140-6736(07)61380-4, PII S0140673607613804
    • Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007 Sep 1; 370 (9589): 765-73 (Pubitemid 47321908)
    • (2007) Lancet , vol.370 , Issue.9589 , pp. 765-773
    • Mannino, D.M.1    Buist, A.S.2
  • 6
    • 0034109837 scopus 로고    scopus 로고
    • Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease
    • Barnes PJ. Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000 Feb; 161 (2 Pt 1): 342-4 (Pubitemid 30129436)
    • (2000) American Journal of Respiratory and Critical Care Medicine , vol.161 , Issue.2 , pp. 342-344
    • Barnes, P.J.1
  • 7
    • 69249124565 scopus 로고    scopus 로고
    • Inhaled corticosteroids in COPD: The case against
    • Jul
    • Suissa S, Barnes PJ. Inhaled corticosteroids in COPD: the case against. Eur Respir J 2009 Jul; 34 (1): 13-6
    • (2009) Eur Respir J , vol.34 , Issue.1 , pp. 13-16
    • Suissa, S.1    Barnes, P.J.2
  • 8
    • 0029740875 scopus 로고    scopus 로고
    • Role of oxidants/antioxidants in smoking-induced lung diseases
    • DOI 10.1016/0891-5849(96)00155-4
    • Rahman I, MacNee W. Role of oxidants/antioxidants in smoking-induced lung diseases. Free Radic Biol Med 1996; 21 (5): 669-81 (Pubitemid 26331096)
    • (1996) Free Radical Biology and Medicine , vol.21 , Issue.5 , pp. 669-681
    • Rahman, I.1    MacNee, W.2
  • 10
    • 80052606325 scopus 로고    scopus 로고
    • Beyond corticosteroids: Future prospects in the management of inflammation in COPD
    • Sep 1
    • Roche N, Marthan R, Berger P, et al. Beyond corticosteroids: future prospects in the management of inflammation in COPD. Eur Respir Rev 2011 Sep 1; 20 (121): 175-82
    • (2011) Eur Respir Rev , vol.20 , Issue.121 , pp. 175-182
    • Roche, N.1    Marthan, R.2    Berger, P.3
  • 11
    • 84857722564 scopus 로고    scopus 로고
    • Assessing and treating small airways disease in asthma and chronic obstructive pulmonary disease
    • Mar
    • Usmani OS, Barnes PJ. Assessing and treating small airways disease in asthma and chronic obstructive pulmonary disease. Ann Med 2012 Mar; 44 (2): 146-56
    • (2012) Ann Med , vol.44 , Issue.2 , pp. 146-156
    • Usmani, O.S.1    Barnes, P.J.2
  • 12
    • 0141928029 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease: Molecular and cellular mechanisms
    • Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003 Oct; 22 (4): 672-88 (Pubitemid 37258549)
    • (2003) European Respiratory Journal , vol.22 , Issue.4 , pp. 672-688
    • Barnes, P.J.1    Shapiro, S.D.2    Pauwels, R.A.3
  • 13
    • 53749106584 scopus 로고    scopus 로고
    • Influence of smoking on airway inflammation and remodelling in asthma
    • Oct
    • St-Laurent J, Bergeron C, Page N, et al. Influence of smoking on airway inflammation and remodelling in asthma. Clin Exp Allergy 2008 Oct; 38 (10): 1582-9
    • (2008) Clin Exp Allergy , vol.38 , Issue.10 , pp. 1582-1589
    • St-Laurent, J.1    Bergeron, C.2    Page, N.3
  • 14
    • 40049104892 scopus 로고    scopus 로고
    • Immunology of asthma and chronic obstructive pulmonary disease
    • DOI 10.1038/nri2254, PII NRI2254
    • Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. NatRev Immunol 2008Mar; 8 (3): 183-92 (Pubitemid 351323287)
    • (2008) Nature Reviews Immunology , vol.8 , Issue.3 , pp. 183-192
    • Barnes, P.J.1
  • 17
    • 0029866161 scopus 로고    scopus 로고
    • Effects of long-term treatment with corticosteroids in COPD
    • Renkema TE, Schouten JP, Koeter GH, et al. Effects of long-term treatment with corticosteroids in COPD. Chest 1996 May; 109 (5): 1156-62 (Pubitemid 26145649)
    • (1996) Chest , vol.109 , Issue.5 , pp. 1156-1162
    • Renkema, T.E.J.1    Schouten, J.P.2    Koeter, G.H.3    Postma, D.S.4
  • 18
    • 0345188819 scopus 로고    scopus 로고
    • Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking
    • DOI 10.1056/NEJM199906243402503
    • Pauwels RA, Lofdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 1999 Jun 24; 340 (25): 1948-53 (Pubitemid 29288270)
    • (1999) New England Journal of Medicine , vol.340 , Issue.25 , pp. 1948-1953
    • Pauwels, R.A.1    Lofdahl, C.-G.2    Laitinen, L.A.3    Schouten, J.P.4    Postma, D.S.5    Pride, N.B.6    Ohlsson, S.V.7
  • 19
    • 0034643610 scopus 로고    scopus 로고
    • Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
    • Burge PS, Calverley PM, Jones PW, et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000 May 13; 320 (7245): 1297-303 (Pubitemid 30245717)
    • (2000) British Medical Journal , vol.320 , Issue.7245 , pp. 1297-1303
    • Burge, P.S.1    Calverley, P.M.A.2    Jones, P.W.3    Spencer, S.4    Anderson, J.A.5    Maslen, T.K.6
  • 20
    • 0033614639 scopus 로고    scopus 로고
    • Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomised controlled trial
    • DOI 10.1016/S0140-6736(98)10019-3
    • Vestbo J, Sorensen T, Lange P, et al. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 1999 May 29; 353 (9167): 1819-23 (Pubitemid 29251012)
    • (1999) Lancet , vol.353 , Issue.9167 , pp. 1819-1823
    • Vestbo, J.1    Sorensen, T.2    Lange, P.3    Brix, A.4    Tone, P.5    Viskum, K.6
  • 21
    • 0032515756 scopus 로고    scopus 로고
    • Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease
    • DOI 10.1016/S0140-6736(97)03471-5
    • Paggiaro PL, Dahle R, Bakran I, et al. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group. Lancet 1998 Mar 14; 351 (9105): 773-80 (Pubitemid 28112338)
    • (1998) Lancet , vol.351 , Issue.9105 , pp. 773-780
    • Paggiaro, P.L.1    Dahle, R.2    Bakran, I.3    Frith, L.4    Hollingworth, K.5    Efthimiou, J.6
  • 22
    • 0038808776 scopus 로고    scopus 로고
    • Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease: A meta-analysis
    • Jun 17
    • Highland KB, Strange C, Heffner JE. Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease: a meta-analysis. Ann Intern Med 2003 Jun 17; 138 (12): 969-73
    • (2003) Ann Intern Med , vol.138 , Issue.12 , pp. 969-973
    • Highland, K.B.1    Strange, C.2    Heffner, J.E.3
  • 23
    • 48949103222 scopus 로고    scopus 로고
    • Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: Results from the TORCH study
    • Aug 15
    • Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008 Aug 15; 178 (4): 332-8
    • (2008) Am J Respir Crit Care Med , vol.178 , Issue.4 , pp. 332-338
    • Celli, B.R.1    Thomas, N.E.2    Anderson, J.A.3
  • 24
    • 34548400452 scopus 로고    scopus 로고
    • Inhaled corticosteroids for stable chronic obstructive pulmonary disease
    • Yang IA, Fong KM, Sim EH, et al. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007; (2): CD002991
    • (2007) Cochrane Database Syst Rev , Issue.2
    • Yang, I.A.1    Fong, K.M.2    Sim, E.H.3
  • 26
    • 20444497934 scopus 로고    scopus 로고
    • Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: A randomised controlled trial
    • DOI 10.1136/thx.2004.034280
    • Wouters EF, Postma DS, Fokkens B, et al. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial. Thorax 2005 Jun; 60 (6): 480-7 (Pubitemid 40814047)
    • (2005) Thorax , vol.60 , Issue.6 , pp. 480-487
    • Wouters, E.F.M.1    Postma, D.S.2    Fokkens, B.3    Hop, W.C.J.4    Prins, J.5    Kuipers, A.F.6    Pasma, H.R.7    Hensing, C.A.J.8    Creutzberg, E.C.9
  • 27
    • 77954814658 scopus 로고    scopus 로고
    • Inhaled corticosteroids in COPD: A controversy
    • Barnes PJ. Inhaled corticosteroids in COPD: a controversy. Respiration 2010; 80 (2): 89-95
    • (2010) Respiration , vol.80 , Issue.2 , pp. 89-95
    • Barnes, P.J.1
  • 28
    • 13644262558 scopus 로고    scopus 로고
    • Growth hormone response to growth hormone-releasing hormone is reduced in adult asthmatic patients receiving long-term inhaled corticosteroid treatment
    • DOI 10.1378/chest.127.2.515
    • Malerba M, Bossoni S, Radaeli A, et al. Growth hormone response to growth hormone-releasing hormone is reduced in adult asthmatic patients receiving long-term inhaled corticosteroid treatment. Chest 2005 Feb; 127 (2): 515-21 (Pubitemid 40229311)
    • (2005) Chest , vol.127 , Issue.2 , pp. 515-521
    • Malerba, M.1    Bossoni, S.2    Radaeli, A.3    Mori, E.4    Bonadonna, S.5    Giustina, A.6    Tantucci, C.7
  • 29
    • 29444460066 scopus 로고    scopus 로고
    • Bone ultrasonometric features and growth hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy
    • DOI 10.1016/j.bone.2005.07.002, PII S8756328205002693
    • Malerba M, Bossoni S, Radaeli A, et al. Bone ultrasonometric features and growth hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy. Bone 2006 Jan; 38 (1): 119-24 (Pubitemid 43008450)
    • (2006) Bone , vol.38 , Issue.1 , pp. 119-124
    • Malerba, M.1    Bossoni, S.2    Radaeli, A.3    Mori, E.4    Romanelli, G.5    Tantucci, C.6    Giustina, A.7    Grassi, V.8
  • 30
    • 0033542041 scopus 로고    scopus 로고
    • Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis
    • DOI 10.1001/archinte.159.9.941
    • Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 1999 May 10; 159 (9): 941-55 (Pubitemid 29222495)
    • (1999) Archives of Internal Medicine , vol.159 , Issue.9 , pp. 941-955
    • Lipworth, B.J.1
  • 31
    • 48249085691 scopus 로고    scopus 로고
    • Cluster analysis and clinical asthma phenotypes
    • Aug 1
    • Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008 Aug 1; 178 (3): 218-24
    • (2008) Am J Respir Crit Care Med , vol.178 , Issue.3 , pp. 218-224
    • Haldar, P.1    Pavord, I.D.2    Shaw, D.E.3
  • 33
    • 80052435472 scopus 로고    scopus 로고
    • Current controversies and future perspectives in chronic obstructive pulmonary disease
    • Sep 1
    • Agusti A, Vestbo J. Current controversies and future perspectives in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011 Sep 1; 184 (5): 507-13
    • (2011) Am J Respir Crit Care Med , vol.184 , Issue.5 , pp. 507-513
    • Agusti, A.1    Vestbo, J.2
  • 34
    • 0028264310 scopus 로고
    • Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
    • DOI 10.1016/S0140-6736(94)92996-3
    • Greening AP, Ind PW, Northfield M, et al. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 1994 Jul 23; 344 (8917): 219-24 (Pubitemid 24229008)
    • (1994) Lancet , vol.344 , Issue.8917 , pp. 219-224
    • Greening, A.P.1    Ind, P.W.2    Northfield, M.3    Shaw, G.4
  • 35
    • 1842370350 scopus 로고    scopus 로고
    • Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group
    • Nov 13
    • Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997 Nov 13; 337 (20): 1405-11
    • (1997) N Engl J Med , vol.337 , Issue.20 , pp. 1405-1411
    • Pauwels, R.A.1    Lofdahl, C.G.2    Postma, D.S.3
  • 36
    • 0032741133 scopus 로고    scopus 로고
    • Asthma quality of life during 1 year of treatment with budesonide with or without formoterol
    • Nov
    • Juniper EF, Svensson K, O'Byrne PM, et al. Asthma quality of life during 1 year of treatment with budesonide with or without formoterol. Eur Respir J 1999 Nov; 14 (5): 1038-43
    • (1999) Eur Respir J , vol.14 , Issue.5 , pp. 1038-1043
    • Juniper, E.F.1    Svensson, K.2    O'Byrne, P.M.3
  • 38
    • 0037180086 scopus 로고    scopus 로고
    • 2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling
    • DOI 10.1016/S0140-6736(02)11319-5
    • Roth M, Johnson PR, Rudiger JJ, et al. Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet 2002 Oct 26; 360 (9342): 1293-9 (Pubitemid 35284621)
    • (2002) Lancet , vol.360 , Issue.9342 , pp. 1293-1299
    • Roth, M.1    Johnson, P.R.A.2    Rudiger, J.J.3    King, G.G.4    Ge, Q.5    Burgess, J.K.6    Anderson, G.7    Tamm, M.8    Black, J.L.9
  • 42
    • 33846318149 scopus 로고    scopus 로고
    • Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease
    • DOI 10.1164/rccm.200602-244OC
    • Kardos P, Wencker M, Glaab T, et al. Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007 Jan 15; 175 (2): 144-9 (Pubitemid 46115085)
    • (2007) American Journal of Respiratory and Critical Care Medicine , vol.175 , Issue.2 , pp. 144-149
    • Kardos, P.1    Wencker, M.2    Glaab, T.3    Vogelmeier, C.4
  • 43
    • 47049130249 scopus 로고    scopus 로고
    • Methodological issues in therapeutic trials of COPD
    • May
    • Suissa S, Ernst P, Vandemheen KL, et al. Methodological issues in therapeutic trials of COPD. Eur Respir J 2008 May; 31 (5): 927-33
    • (2008) Eur Respir J , vol.31 , Issue.5 , pp. 927-933
    • Suissa, S.1    Ernst, P.2    Vandemheen, K.L.3
  • 44
    • 34347340694 scopus 로고    scopus 로고
    • Prevention of death in COPD
    • May 24
    • La Vecchia C, Fabbri LM. Prevention of death in COPD. N Engl J Med 2007 May 24; 356 (21): 2211-4
    • (2007) N Engl J Med , vol.356 , Issue.21 , pp. 2211-2214
    • La Vecchia, C.1    Fabbri, L.M.2
  • 45
    • 40949119305 scopus 로고    scopus 로고
    • Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
    • Nannini L, Cates CJ, Lasserson TJ, Poole P. Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007; (4): CD003794
    • (2007) Cochrane Database Syst Rev , Issue.4
    • Nannini, L.1    Cates, C.J.2    Lasserson, T.J.3    Poole, P.4
  • 46
    • 70349088498 scopus 로고    scopus 로고
    • Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results
    • Sep
    • Crim C, Calverley PM, Anderson JA, et al. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 2009 Sep; 34 (3): 641-7
    • (2009) Eur Respir J , vol.34 , Issue.3 , pp. 641-647
    • Crim, C.1    Calverley, P.M.2    Anderson, J.A.3
  • 47
    • 12944257305 scopus 로고    scopus 로고
    • The influence of smoking on the treatment response in patients with asthma
    • Thomson NC, Spears M. The influence of smoking on the treatment response in patients with asthma. Curr Opin Allergy Clin Immunol 2005 Feb; 5 (1): 57-63 (Pubitemid 40175497)
    • (2005) Current Opinion in Allergy and Clinical Immunology , vol.5 , Issue.1 , pp. 57-63
    • Thomson, N.C.1    Spears, M.2
  • 51
    • 0032696013 scopus 로고    scopus 로고
    • Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease
    • Nov
    • Culpitt SV, Maziak W, Loukidis S, et al. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999 Nov; 160 (5 Pt 1): 1635-9
    • (1999) Am J Respir Crit Care Med , vol.160 , Issue.5 PART 1 , pp. 1635-1639
    • Culpitt, S.V.1    Maziak, W.2    Loukidis, S.3
  • 52
    • 0037097883 scopus 로고    scopus 로고
    • The effects of inhaled fluticasone on airway inflammation in Chronic Obstructive Pulmonary Disease: A double-blind, placebo-controlled biopsy study
    • DOI 10.1164/rccm.2105025
    • Hattotuwa KL, Gizycki MJ, Ansari TW, et al. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebocontrolled biopsy study. Am J Respir Crit Care Med 2002 Jun 15; 165 (12): 1592-6 (Pubitemid 34693937)
    • (2002) American Journal of Respiratory and Critical Care Medicine , vol.165 , Issue.12 , pp. 1592-1596
    • Hattotuwa, K.L.1    Gizycki, M.J.2    Ansari, T.W.3    Jeffery, P.K.4    Barnes, N.C.5
  • 53
    • 33644784718 scopus 로고    scopus 로고
    • Corticosteroids: The drugs to beat
    • DOI 10.1016/j.ejphar.2005.12.052, PII S0014299905013816, The Pharmacology of the Respiratory Tract
    • Barnes PJ. Corticosteroids: the drugs to beat. Eur J Pharmacol 2006 Mar 8; 533 (1-3): 2-14 (Pubitemid 43340000)
    • (2006) European Journal of Pharmacology , vol.533 , Issue.1-3 , pp. 2-14
    • Barnes, P.J.1
  • 54
    • 79953726304 scopus 로고    scopus 로고
    • Glucocorticosteroids: Current and future directions
    • May
    • Barnes PJ. Glucocorticosteroids: current and future directions. Br J Pharmacol 2011 May; 163 (1): 29-43
    • (2011) Br J Pharmacol , vol.163 , Issue.1 , pp. 29-43
    • Barnes, P.J.1
  • 55
    • 77954790495 scopus 로고    scopus 로고
    • New therapies for chronic obstructive pulmonary disease
    • Barnes PJ. New therapies for chronic obstructive pulmonary disease. Med Princ Pract 2010; 19 (5): 330-8
    • (2010) Med Princ Pract , vol.19 , Issue.5 , pp. 330-338
    • Barnes, P.J.1
  • 56
    • 77953924437 scopus 로고    scopus 로고
    • Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients
    • Jun
    • De Backer W, Devolder A, Poli G, et al. Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients. J Aerosol Med Pulm Drug Deliv 2010 Jun; 23 (3): 137-48
    • (2010) J Aerosol Med Pulm Drug Deliv , vol.23 , Issue.3 , pp. 137-148
    • De Backer, W.1    Devolder, A.2    Poli, G.3
  • 59
    • 0033064218 scopus 로고    scopus 로고
    • Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: No significant effect of cigarette smoking
    • DOI 10.1053/rmed.1999.0574
    • Nowak D, Kasielski M, Antczak A, et al. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 1999 Jun; 93 (6): 389-96 (Pubitemid 29265348)
    • (1999) Respiratory Medicine , vol.93 , Issue.6 , pp. 389-396
    • Nowak, D.1    Kasielski, M.2    Antczak, A.3    Pietras, T.4    Bialasiewicz, P.5
  • 60
    • 0842308109 scopus 로고    scopus 로고
    • Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: Role of tyrosine nitration
    • DOI 10.1016/j.bbrc.2004.01.046
    • Ito K, Hanazawa T, Tomita K, et al. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun 2004 Feb 27; 315 (1): 240-5 (Pubitemid 38175212)
    • (2004) Biochemical and Biophysical Research Communications , vol.315 , Issue.1 , pp. 240-245
    • Ito, K.1    Hanazawa, T.2    Tomita, K.3    Barnes, P.J.4    Adcock, I.M.5
  • 61
    • 65249151877 scopus 로고    scopus 로고
    • Inhibition of PI3Kdelta restores glucocorticoid function in smokinginduced airway inflammation in mice
    • Apr 1
    • Marwick JA, Caramori G, Stevenson CS, et al. Inhibition of PI3Kdelta restores glucocorticoid function in smokinginduced airway inflammation in mice. Am J Respir Crit Care Med 2009 Apr 1; 179 (7): 542-8
    • (2009) Am J Respir Crit Care Med , vol.179 , Issue.7 , pp. 542-548
    • Marwick, J.A.1    Caramori, G.2    Stevenson, C.S.3
  • 62
    • 77958173826 scopus 로고    scopus 로고
    • Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease
    • Oct 1
    • To Y, Ito K, Kizawa Y, et al. Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010 Oct 1; 182 (7): 897-904
    • (2010) Am J Respir Crit Care Med , vol.182 , Issue.7 , pp. 897-904
    • To, Y.1    Ito, K.2    Kizawa, Y.3
  • 64
    • 2342567291 scopus 로고    scopus 로고
    • Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients
    • DOI 10.1016/j.jaci.2004.03.018, PII S0091674904011509
    • Matthews JG, Ito K, Barnes PJ, et al. Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. JAllergy Clin Immunol 2004 Jun; 113 (6): 1100-8 (Pubitemid 38857992)
    • (2004) Journal of Allergy and Clinical Immunology , vol.113 , Issue.6 , pp. 1100-1108
    • Matthews, J.G.1    Ito, K.2    Barnes, P.J.3    Adcock, I.M.4
  • 65
    • 0036231010 scopus 로고    scopus 로고
    • P38 mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: Role in steroid-insensitive asthma
    • DOI 10.1067/mai.2002.122465
    • Irusen E, Matthews JG, Takahashi A, et al. p38 Mitogenactivated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J Allergy Clin Immunol 2002 Apr; 109 (4): 649-57 (Pubitemid 34327193)
    • (2002) Journal of Allergy and Clinical Immunology , vol.109 , Issue.4 , pp. 649-657
    • Irusen, E.1    Matthews, J.G.2    Takahashi, A.3    Barnes, P.J.4    Chung, K.F.5    Adcock, I.M.6
  • 66
    • 83255187892 scopus 로고    scopus 로고
    • Ligandindependent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling
    • Dec
    • Galliher-Beckley AJ, Williams JG, Cidlowski JA. Ligandindependent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling. Mol Cell Biol 2011 Dec; 31 (23): 4663-75
    • (2011) Mol Cell Biol , vol.31 , Issue.23 , pp. 4663-4675
    • Galliher-Beckley, A.J.1    Williams, J.G.2    Cidlowski, J.A.3
  • 67
    • 34948900221 scopus 로고    scopus 로고
    • Steroid receptor phosphorylation: A key modulator of multiple receptor functions
    • DOI 10.1210/me.2007-0101
    • Weigel NL, Moore NL. Steroid receptor phosphorylation: a key modulator of multiple receptor functions. Mol Endocrinol 2007 Oct; 21 (10): 2311-9 (Pubitemid 47529347)
    • (2007) Molecular Endocrinology , vol.21 , Issue.10 , pp. 2311-2319
    • Weigel, N.L.1    Moore, N.L.2
  • 69
    • 2342447986 scopus 로고    scopus 로고
    • Importin 7 and Importin α/Importin β Are Nuclear Import Receptors for the Glucocorticoid Receptor
    • DOI 10.1091/mbc.E03-11-0839
    • Freedman ND, Yamamoto KR. Importin 7 and importin alpha/importin beta are nuclear import receptors for the glucocorticoid receptor. Mol Biol Cell 2004 May; 15 (5): 2276-86 (Pubitemid 38580645)
    • (2004) Molecular Biology of the Cell , vol.15 , Issue.5 , pp. 2276-2286
    • Freedman, N.D.1    Yamamoto, K.R.2
  • 70
    • 42649146208 scopus 로고    scopus 로고
    • SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease
    • DOI 10.1164/rccm.200708-1269OC
    • Rajendrasozhan S, Yang SR, Kinnula VL, et al. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008 Apr 15; 177 (8): 861-70 (Pubitemid 351600664)
    • (2008) American Journal of Respiratory and Critical Care Medicine , vol.177 , Issue.8 , pp. 861-870
    • Rajendrasozhan, S.1    Yang, S.-R.2    Kinnula, V.L.3    Rahman, I.4
  • 71
    • 33746674992 scopus 로고    scopus 로고
    • Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid- resistant asthmatic patients
    • DOI 10.1016/j.jaci.2006.04.055, PII S0091674906010566
    • Loke TK, Mallett KH, Ratoff J, et al. Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patients. JAllergy Clin Immunol 2006 Aug; 118 (2): 368-75 (Pubitemid 44160720)
    • (2006) Journal of Allergy and Clinical Immunology , vol.118 , Issue.2 , pp. 368-375
    • Loke, T.-K.1    Mallett, K.H.2    Ratoff, J.3    O'Connor, B.J.4    Ying, S.5    Meng, Q.6    Soh, C.7    Lee, T.H.8    Corrigan, C.J.9
  • 72
    • 0028881859 scopus 로고
    • Abnormal glucocorticoid receptor-activator protein 1 interaction in steroidresistant asthma
    • Dec 1
    • Adcock IM, Lane SJ, Brown CR, et al. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroidresistant asthma. J ExpMed 1995 Dec 1; 182 (6): 1951-8
    • (1995) J ExpMed , vol.182 , Issue.6 , pp. 1951-1958
    • Adcock, I.M.1    Lane, S.J.2    Brown, C.R.3
  • 74
    • 66749146095 scopus 로고    scopus 로고
    • Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: A pilot study
    • May
    • Spears M, Donnelly I, Jolly L, et al. Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: a pilot study. Eur Respir J 2009 May; 33 (5): 1010-7
    • (2009) Eur Respir J , vol.33 , Issue.5 , pp. 1010-1017
    • Spears, M.1    Donnelly, I.2    Jolly, L.3
  • 75
    • 57349099228 scopus 로고    scopus 로고
    • Emerging pharmacotherapies for COPD
    • Dec
    • Barnes PJ. Emerging pharmacotherapies for COPD. Chest 2008 Dec; 134 (6): 1278-86
    • (2008) Chest , vol.134 , Issue.6 , pp. 1278-1286
    • Barnes, P.J.1
  • 76
    • 33744832661 scopus 로고    scopus 로고
    • Oxidative stress in asthma and COPD: Antioxidants as a therapeutic strategy
    • DOI 10.1016/j.pharmthera.2005.10.015, PII S0163725805002767
    • Kirkham P, Rahman I. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther 2006 Aug; 111 (2): 476-94 (Pubitemid 43832007)
    • (2006) Pharmacology and Therapeutics , vol.111 , Issue.2 , pp. 476-494
    • Kirkham, P.1    Rahman, I.2
  • 77
    • 58549105575 scopus 로고    scopus 로고
    • Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice
    • Jan 6
    • Sussan TE, Rangasamy T, Blake DJ, et al. Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proc Natl Acad Sci USA 2009 Jan 6; 106 (1): 250-5
    • (2009) Proc Natl Acad Sci USA , vol.106 , Issue.1 , pp. 250-255
    • Sussan, T.E.1    Rangasamy, T.2    Blake, D.J.3
  • 78
    • 0040370216 scopus 로고    scopus 로고
    • Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest
    • DOI 10.1021/bi990842e
    • Zuo Z, Urban G, Scammell JG, et al. Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest. Biochemistry 1999 Jul 13; 38 (28): 8849-57 (Pubitemid 29334645)
    • (1999) Biochemistry , vol.38 , Issue.28 , pp. 8849-8857
    • Zuo, Z.1    Urban, G.2    Scammell, J.G.3    Dean, N.M.4    McLean, T.K.5    Aragon, I.6    Honkanen, R.E.7
  • 79
    • 34447095246 scopus 로고    scopus 로고
    • Phosphoinositide 3-kinase signalling in lung disease: Leucocytes and beyond
    • DOI 10.1111/j.1365-2567.2007.02663.x
    • Medina-Tato DA, Ward SG, Watson ML. Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond. Immunology 2007 Aug; 121 (4): 448-61 (Pubitemid 47030097)
    • (2007) Immunology , vol.121 , Issue.4 , pp. 448-461
    • Medina-Tato, D.A.1    Ward, S.G.2    Watson, M.L.3
  • 80
    • 62449213953 scopus 로고    scopus 로고
    • Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease
    • Mar
    • Doukas J, Eide L, Stebbins K, et al. Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl) pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease. J Pharmacol Exp Ther 2009 Mar; 328 (3): 758-65
    • (2009) J Pharmacol Exp Ther , vol.328 , Issue.3 , pp. 758-765
    • Doukas, J.1    Eide, L.2    Stebbins, K.3
  • 81
    • 77951961401 scopus 로고    scopus 로고
    • Phosphoinositide 3-kinase gamma required for lipopolysaccharide-induced transepithelial neutrophil trafficking in the lung
    • May
    • Reutershan J, Saprito MS, Wu D, et al. Phosphoinositide 3-kinase gamma required for lipopolysaccharide-induced transepithelial neutrophil trafficking in the lung. Eur Respir J 2010 May; 35 (5): 1137-47
    • (2010) Eur Respir J , vol.35 , Issue.5 , pp. 1137-1147
    • Reutershan, J.1    Saprito, M.S.2    Wu, D.3
  • 82
    • 0037350266 scopus 로고    scopus 로고
    • Therapeutic potential of phosphoinositide 3-kinase inhibitors
    • DOI 10.1016/S1074-5521(03)00048-6
    • Ward S, Sotsios Y, Dowden J, et al. Therapeutic potential of phosphoinositide 3-kinase inhibitors. Chem Biol 2003 Mar; 10 (3): 207-13 (Pubitemid 36380277)
    • (2003) Chemistry and Biology , vol.10 , Issue.3 , pp. 207-213
    • Ward, S.1    Sotsios, Y.2    Dowden, J.3    Bruce, I.4    Finan, P.5
  • 83
    • 52949103280 scopus 로고    scopus 로고
    • Can the anti-inflammatory potential of PDE4 inhibitors be realized: Guarded optimism or wishful thinking?
    • Oct
    • Giembycz MA. Can the anti-inflammatory potential of PDE4 inhibitors be realized: guarded optimism or wishful thinking? Br J Pharmacol 2008 Oct; 155 (3): 288-90
    • (2008) Br J Pharmacol , vol.155 , Issue.3 , pp. 288-290
    • Giembycz, M.A.1
  • 86
    • 69149098943 scopus 로고    scopus 로고
    • Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: Two randomised clinical trials
    • Aug 29
    • Fabbri LM, Calverley PM, Izquierdo-Alonso JL, et al. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet 2009 Aug 29; 374 (9691): 695-703
    • (2009) Lancet , vol.374 , Issue.9691 , pp. 695-703
    • Fabbri, L.M.1    Calverley, P.M.2    Izquierdo-Alonso, J.L.3
  • 87
    • 84872219597 scopus 로고    scopus 로고
    • GlaxoSmithKline [ClinicalTrials.gov identifier NCT00549679]. US National Institutes of Health, ClinicalTrials. gov [online] [Accessed 2012 May 3]
    • GlaxoSmithKline. Study to evaluate safety and tolerability of GSK256066 in chronic obstructive pulmonary disease (COPD) patients [ClinicalTrials.gov identifier NCT00549679]. US National Institutes of Health, ClinicalTrials. gov [online]. Available from URL: http://clin icaltrials.gov [Accessed 2012 May 3]
    • Study to Evaluate Safety and Tolerability of GSK256066 in Chronic Obstructive Pulmonary Disease (COPD) Patients
  • 88
    • 27644589238 scopus 로고    scopus 로고
    • Phosphodiesterase-4: Selective and dual-specificity inhibitors for the therapy of chronic obstructive pulmonary disease
    • DOI 10.1513/pats.200504-041SR
    • Giembycz MA. Phosphodiesterase-4: selective and dualspecificity inhibitors for the therapy of chronic obstructive pulmonary disease. ProcAmThorac Soc 2005; 2 (4): 326-33; discussion 40-1 (Pubitemid 41566944)
    • (2005) Proceedings of the American Thoracic Society , vol.2 , Issue.4 , pp. 326-333
    • Giembycz, M.A.1
  • 89
    • 70350345805 scopus 로고    scopus 로고
    • Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease
    • Jul
    • Banner KH, Press NJ. Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease. Br J Pharmacol 2009 Jul; 157 (6): 892-906
    • (2009) Br J Pharmacol , vol.157 , Issue.6 , pp. 892-906
    • Banner, K.H.1    Press, N.J.2
  • 90
    • 33745939122 scopus 로고    scopus 로고
    • The pharmacology of two novel long-acting phosphodiesterase 3/4 inhibitors, RPL554 [9,10-dimethoxy-2(2,4,6-trimethylphenylimino)-3-(N-carbamoyl- 2- aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4H-pyrimido[6,1-a] isoquinolin-4-one]
    • DOI 10.1124/jpet.105.099192
    • Boswell-Smith V, Spina D, Oxford AW, et al. The pharmacology of two novel long-acting phosphodiesterase 3/4 inhibitors, RPL554 [9,10-dimethoxy-2(2,4,6- trimethylphenylimino)-3-(n-carbamoyl-2-aminoethyl)-3,4,6, 7-tetrahydro-2H- pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-dihydro-2-(2,6- diisopropylphenoxy)-9,10-dimethoxy-4Hpyrimido[ 6,1-a]isoquino lin-4-one]. J Pharmacol Exp Ther 2006 Aug; 318 (2): 840-8 (Pubitemid 44061259)
    • (2006) Journal of Pharmacology and Experimental Therapeutics , vol.318 , Issue.2 , pp. 840-848
    • Boswell-Smith, V.1    Spina, D.2    Oxford, A.W.3    Comer, M.B.4    Seeds, E.A.5    Page, C.P.6
  • 91
    • 84863222610 scopus 로고    scopus 로고
    • Emerging antiinflammatory strategies for chronic obstructive pulmonary disease
    • Epub Apr 10
    • Cazzola M, Page CP, Calzetta L, et al. Emerging antiinflammatory strategies for chronic obstructive pulmonary disease. Eur Respir J. Epub 2012 Apr 10
    • (2012) Eur Respir J.
    • Cazzola, M.1    Page, C.P.2    Calzetta, L.3
  • 92
    • 44649153952 scopus 로고    scopus 로고
    • Increased activation of p38 MAPK in COPD
    • Jan
    • Renda T, Baraldo S, Pelaia G, et al. Increased activation of p38 MAPK in COPD. Eur Respir J 2008 Jan; 31 (1): 62-9
    • (2008) Eur Respir J , vol.31 , Issue.1 , pp. 62-69
    • Renda, T.1    Baraldo, S.2    Pelaia, G.3
  • 93
    • 40849119969 scopus 로고    scopus 로고
    • P38α-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation
    • DOI 10.1124/jpet.107.127092
    • Medicherla S, Fitzgerald MF, Spicer D, et al. p38alphaselective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation. J Pharmacol Exp Ther 2008 Mar; 324 (3): 921-9 (Pubitemid 351397845)
    • (2008) Journal of Pharmacology and Experimental Therapeutics , vol.324 , Issue.3 , pp. 921-929
    • Medicherla, S.1    Fitzgerald, M.F.2    Spicer, D.3
  • 94
    • 84860172730 scopus 로고    scopus 로고
    • An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease
    • Mar
    • Lomas DA, Lipson DA, Miller BE, et al. An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease. J Clin Pharmacol 2012 Mar; 52 (3): 416-24
    • (2012) J Clin Pharmacol , vol.52 , Issue.3 , pp. 416-424
    • Lomas, D.A.1    Lipson, D.A.2    Miller, B.E.3
  • 95
    • 79958710208 scopus 로고    scopus 로고
    • P38 mitogen-activated protein kinase pathways in asthma and COPD
    • Jun
    • Chung KF. p38 mitogen-activated protein kinase pathways in asthma and COPD. Chest 2011 Jun; 139 (6): 1470-9
    • (2011) Chest , vol.139 , Issue.6 , pp. 1470-1479
    • Chung, K.F.1
  • 97
    • 33846411054 scopus 로고    scopus 로고
    • Inhibition of tumor necrosis factor-α-inducible inflammatory genes by interferon-γ is associated with altered nuclear factor-κB transactivation and enhanced histone deacetylase activity
    • DOI 10.1124/mol.106.030171
    • Keslacy S, Tliba O, Baidouri H, et al. Inhibition of tumor necrosis factor-alpha-inducible inflammatory genes by interferon-gamma is associated with altered nuclear factor-kappaB transactivation and enhanced histone deacetylase activity. Mol Pharmacol 2007 Feb; 71 (2): 609-18 (Pubitemid 46147925)
    • (2007) Molecular Pharmacology , vol.71 , Issue.2 , pp. 609-618
    • Keslacy, S.1    Tliba, O.2    Baidouri, H.3    Amrani, Y.4
  • 98
    • 33746217403 scopus 로고    scopus 로고
    • Validation of the anti-inflammatory properties of small-molecule IκB kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle
    • DOI 10.1124/mol.106.023150
    • Catley MC, Sukkar MB, Chung KF, et al. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviralmediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle. Mol Pharmacol 2006 Aug; 70 (2): 697-705 (Pubitemid 44092330)
    • (2006) Molecular Pharmacology , vol.70 , Issue.2 , pp. 697-705
    • Catley, M.C.1    Sukkar, M.B.2    Chung, K.F.3    Jaffee, B.4    Liao, S.-M.5    Coyle, A.J.6    Haddad, E.-B.7    Barnes, P.J.8    Newton, R.9
  • 99
    • 33748580720 scopus 로고    scopus 로고
    • Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease
    • DOI 10.1016/j.tips.2006.08.001, PII S0165614706001817
    • Donnelly LE, Barnes PJ. Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease. Trends Pharmacol Sci 2006 Oct; 27 (10): 546-53 (Pubitemid 44374756)
    • (2006) Trends in Pharmacological Sciences , vol.27 , Issue.10 , pp. 546-553
    • Donnelly, L.E.1    Barnes, P.J.2
  • 100
    • 38349077242 scopus 로고    scopus 로고
    • CXCR3 and CCR5 chemokines in induced sputum from patients with COPD
    • Jan
    • Costa C, Rufino R, Traves SL, et al. CXCR3 and CCR5 chemokines in induced sputum from patients with COPD. Chest 2008 Jan; 133 (1): 26-33
    • (2008) Chest , vol.133 , Issue.1 , pp. 26-33
    • Costa, C.1    Rufino, R.2    Traves, S.L.3
  • 102
    • 33750102235 scopus 로고    scopus 로고
    • Tocilizumab: Blockade of interleukin-6 signaling pathway as a therapeutic strategy for inflammatory disorders
    • DOI 10.1358/dot.2006.42.9.1025692
    • Paul-Pletzer K. Tocilizumab: blockade of interleukin-6 signaling pathway as a therapeutic strategy for inflammatory disorders. Drugs Today (Barc) 2006 Sep; 42 (9): 559-76 (Pubitemid 44595080)
    • (2006) Drugs of Today , vol.42 , Issue.9 , pp. 559-576
    • Paul-Pletzer, K.1
  • 105
    • 34547815598 scopus 로고    scopus 로고
    • Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs
    • DOI 10.1136/thx.2006.068353
    • ChurgA,WangR,WangX, et al. Effect of anMMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs. Thorax 2007 Aug; 62 (8): 706-13 (Pubitemid 47235016)
    • (2007) Thorax , vol.62 , Issue.8 , pp. 706-713
    • Churg, A.1    Wang, R.2    Wang, X.3    Onnervik, P.-O.4    Thim, K.5    Wright, J.L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.